Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice

Pao Pao Yang, Geng Chang Yeh, Teng Kuang Yeh, Jinghua Xi, Horace H. Loh, Ping Yee Law, Pao Luh Tao

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Oxycodone has been used clinically for over 90 years. While it is known that it exhibits low affinity for the multiple opioid receptors, whether its pharmacological activities are due to oxycodone activation of the opioid receptor type or due to its active metabolite (oxymorphone) that exhibits high affinity for the mu-opioid receptors remains unresolved. Ross and Smith (1997) reported the antinociceptive effects of oxycodone (171 nmol, i.c.v.) are induced by putative kappa-opioid receptors in SD rat while others have reported oxycodone activities are due to activation of mu- and/or delta-opioid receptors. In this study, using male mu-opioid receptor knock-out (MOR-KO) mice, we examined whether delta-opioid receptor was involved in oxycodone antinociception. Systemic subcutaneous (s.c.) administration of oxycodone (above 40 mg/kg) could induce a small but significant antinociceptive effect in MOR-KO mice by the tail flick test. Delta-opioid receptor antagonist (naltrindole, 10 mg/kg or 20 mg/kg, i.p.) could block this effect. When oxycodone was injected directly into the brain of MOR-KO mice by intracerebroventricular (i.c.v.) route, oxycodone at doses of 50 nmol or higher could induce similar level of antinociceptive responses to those observed in wild type mice at the same doses by i.c.v. Delta-opioid receptor antagonists (naltrindole at 10 nmol or ICI 154,129 at 20 μg) completely blocked the supraspinal antinociceptive effect of oxycodone in MOR-KO mice. Such oxycodone antinociceptive responses were probably not due to its active metabolites oxymorphone because (a) the relative low level of oxymorphone was found in the brain after systemically or centrally oxycodone injection using LC/MS/MS analysis; (b) oxymorphone at a dose that mimics the level detected in the mice brain did not show any significant antinocieption effect; (c) oxycodone exhibits equal potency as oxymorphone albeit being a partial agonist in regulating [Ca2+]I transients in a clonal cell line expressing high level of mu-opioid receptor. These data suggest that oxycodone by itself can activate both the mu- and delta-opioid receptors and that delta-opioid receptors may contribute to the central antinociceptive effect of oxycodone in mice.

Original languageEnglish
Pages (from-to)867-876
Number of pages10
JournalPharmacological Research
Volume111
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Oxycodone
delta Opioid Receptor
mu Opioid Receptor
Oxymorphone
naltrindole
Knockout Mice
Narcotic Antagonists
Opioid Receptors
Brain
kappa Opioid Receptor

Keywords

  • Antinociceptive
  • Opioid receptors
  • Oxycodone
  • Oxymorphone

ASJC Scopus subject areas

  • Pharmacology

Cite this

Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice. / Yang, Pao Pao; Yeh, Geng Chang; Yeh, Teng Kuang; Xi, Jinghua; Loh, Horace H.; Law, Ping Yee; Tao, Pao Luh.

In: Pharmacological Research, Vol. 111, 01.09.2016, p. 867-876.

Research output: Contribution to journalArticle

Yang, Pao Pao ; Yeh, Geng Chang ; Yeh, Teng Kuang ; Xi, Jinghua ; Loh, Horace H. ; Law, Ping Yee ; Tao, Pao Luh. / Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice. In: Pharmacological Research. 2016 ; Vol. 111. pp. 867-876.
@article{2be7a23a6f994f3b89f0b29bdb5be3a6,
title = "Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice",
abstract = "Oxycodone has been used clinically for over 90 years. While it is known that it exhibits low affinity for the multiple opioid receptors, whether its pharmacological activities are due to oxycodone activation of the opioid receptor type or due to its active metabolite (oxymorphone) that exhibits high affinity for the mu-opioid receptors remains unresolved. Ross and Smith (1997) reported the antinociceptive effects of oxycodone (171 nmol, i.c.v.) are induced by putative kappa-opioid receptors in SD rat while others have reported oxycodone activities are due to activation of mu- and/or delta-opioid receptors. In this study, using male mu-opioid receptor knock-out (MOR-KO) mice, we examined whether delta-opioid receptor was involved in oxycodone antinociception. Systemic subcutaneous (s.c.) administration of oxycodone (above 40 mg/kg) could induce a small but significant antinociceptive effect in MOR-KO mice by the tail flick test. Delta-opioid receptor antagonist (naltrindole, 10 mg/kg or 20 mg/kg, i.p.) could block this effect. When oxycodone was injected directly into the brain of MOR-KO mice by intracerebroventricular (i.c.v.) route, oxycodone at doses of 50 nmol or higher could induce similar level of antinociceptive responses to those observed in wild type mice at the same doses by i.c.v. Delta-opioid receptor antagonists (naltrindole at 10 nmol or ICI 154,129 at 20 μg) completely blocked the supraspinal antinociceptive effect of oxycodone in MOR-KO mice. Such oxycodone antinociceptive responses were probably not due to its active metabolites oxymorphone because (a) the relative low level of oxymorphone was found in the brain after systemically or centrally oxycodone injection using LC/MS/MS analysis; (b) oxymorphone at a dose that mimics the level detected in the mice brain did not show any significant antinocieption effect; (c) oxycodone exhibits equal potency as oxymorphone albeit being a partial agonist in regulating [Ca2+]I transients in a clonal cell line expressing high level of mu-opioid receptor. These data suggest that oxycodone by itself can activate both the mu- and delta-opioid receptors and that delta-opioid receptors may contribute to the central antinociceptive effect of oxycodone in mice.",
keywords = "Antinociceptive, Opioid receptors, Oxycodone, Oxymorphone",
author = "Yang, {Pao Pao} and Yeh, {Geng Chang} and Yeh, {Teng Kuang} and Jinghua Xi and Loh, {Horace H.} and Law, {Ping Yee} and Tao, {Pao Luh}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.phrs.2016.05.034",
language = "English",
volume = "111",
pages = "867--876",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice

AU - Yang, Pao Pao

AU - Yeh, Geng Chang

AU - Yeh, Teng Kuang

AU - Xi, Jinghua

AU - Loh, Horace H.

AU - Law, Ping Yee

AU - Tao, Pao Luh

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Oxycodone has been used clinically for over 90 years. While it is known that it exhibits low affinity for the multiple opioid receptors, whether its pharmacological activities are due to oxycodone activation of the opioid receptor type or due to its active metabolite (oxymorphone) that exhibits high affinity for the mu-opioid receptors remains unresolved. Ross and Smith (1997) reported the antinociceptive effects of oxycodone (171 nmol, i.c.v.) are induced by putative kappa-opioid receptors in SD rat while others have reported oxycodone activities are due to activation of mu- and/or delta-opioid receptors. In this study, using male mu-opioid receptor knock-out (MOR-KO) mice, we examined whether delta-opioid receptor was involved in oxycodone antinociception. Systemic subcutaneous (s.c.) administration of oxycodone (above 40 mg/kg) could induce a small but significant antinociceptive effect in MOR-KO mice by the tail flick test. Delta-opioid receptor antagonist (naltrindole, 10 mg/kg or 20 mg/kg, i.p.) could block this effect. When oxycodone was injected directly into the brain of MOR-KO mice by intracerebroventricular (i.c.v.) route, oxycodone at doses of 50 nmol or higher could induce similar level of antinociceptive responses to those observed in wild type mice at the same doses by i.c.v. Delta-opioid receptor antagonists (naltrindole at 10 nmol or ICI 154,129 at 20 μg) completely blocked the supraspinal antinociceptive effect of oxycodone in MOR-KO mice. Such oxycodone antinociceptive responses were probably not due to its active metabolites oxymorphone because (a) the relative low level of oxymorphone was found in the brain after systemically or centrally oxycodone injection using LC/MS/MS analysis; (b) oxymorphone at a dose that mimics the level detected in the mice brain did not show any significant antinocieption effect; (c) oxycodone exhibits equal potency as oxymorphone albeit being a partial agonist in regulating [Ca2+]I transients in a clonal cell line expressing high level of mu-opioid receptor. These data suggest that oxycodone by itself can activate both the mu- and delta-opioid receptors and that delta-opioid receptors may contribute to the central antinociceptive effect of oxycodone in mice.

AB - Oxycodone has been used clinically for over 90 years. While it is known that it exhibits low affinity for the multiple opioid receptors, whether its pharmacological activities are due to oxycodone activation of the opioid receptor type or due to its active metabolite (oxymorphone) that exhibits high affinity for the mu-opioid receptors remains unresolved. Ross and Smith (1997) reported the antinociceptive effects of oxycodone (171 nmol, i.c.v.) are induced by putative kappa-opioid receptors in SD rat while others have reported oxycodone activities are due to activation of mu- and/or delta-opioid receptors. In this study, using male mu-opioid receptor knock-out (MOR-KO) mice, we examined whether delta-opioid receptor was involved in oxycodone antinociception. Systemic subcutaneous (s.c.) administration of oxycodone (above 40 mg/kg) could induce a small but significant antinociceptive effect in MOR-KO mice by the tail flick test. Delta-opioid receptor antagonist (naltrindole, 10 mg/kg or 20 mg/kg, i.p.) could block this effect. When oxycodone was injected directly into the brain of MOR-KO mice by intracerebroventricular (i.c.v.) route, oxycodone at doses of 50 nmol or higher could induce similar level of antinociceptive responses to those observed in wild type mice at the same doses by i.c.v. Delta-opioid receptor antagonists (naltrindole at 10 nmol or ICI 154,129 at 20 μg) completely blocked the supraspinal antinociceptive effect of oxycodone in MOR-KO mice. Such oxycodone antinociceptive responses were probably not due to its active metabolites oxymorphone because (a) the relative low level of oxymorphone was found in the brain after systemically or centrally oxycodone injection using LC/MS/MS analysis; (b) oxymorphone at a dose that mimics the level detected in the mice brain did not show any significant antinocieption effect; (c) oxycodone exhibits equal potency as oxymorphone albeit being a partial agonist in regulating [Ca2+]I transients in a clonal cell line expressing high level of mu-opioid receptor. These data suggest that oxycodone by itself can activate both the mu- and delta-opioid receptors and that delta-opioid receptors may contribute to the central antinociceptive effect of oxycodone in mice.

KW - Antinociceptive

KW - Opioid receptors

KW - Oxycodone

KW - Oxymorphone

UR - http://www.scopus.com/inward/record.url?scp=84982797763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982797763&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2016.05.034

DO - 10.1016/j.phrs.2016.05.034

M3 - Article

C2 - 27496654

AN - SCOPUS:84982797763

VL - 111

SP - 867

EP - 876

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -